ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

ClinicalTrials.gov ID: NCT02636868

Public ClinicalTrials.gov record NCT02636868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome

Study identification

NCT ID
NCT02636868
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Windtree Therapeutics
Industry
Enrollment
221 participants

Conditions and interventions

Interventions

  • Lucinactant delivered via investigational delivery device Drug
  • nCPAP Drug

Drug

Eligibility (public fields only)

Age range
26 Weeks to 32 Weeks
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Jun 30, 2017
Completion
Aug 5, 2019
Last update posted
Apr 22, 2021

2015 – 2019

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249
Univ. of Arkansas Medical Center Little Rock Arkansas 72202
Loma Linda University Medical Center Loma Linda California 92354
Children's Hospital of Orange County Orange California 92868
Sharp Mary Birch Hospital for Women and Newborns San Diego California 92123
Christiana Care Health System Newark Delaware 19713
University of Miami Holtz Children's Hospital Miami Florida 33136
University of Michigan Health System Ann Arbor Michigan 48109
University of Mississippi Medical Center Jackson Mississippi 39216
University of Nebraska Medical Center Omaha Nebraska 68105
Albany Medical Center Albany New York 12208
Morgan Stanley Childrens Hospital of New York Presbyterian (CHONY) New York New York 10032
Duke University Medical Center Durham North Carolina 27710
Brody School of Medicine at ECU Greenville North Carolina 27834
New Hanover Regional Medical Center Wilmington North Carolina 28401
Case Western Reserve University (Rainbow Babies Hosp.) Cleveland Ohio 44106
Ohio State University Columbus Ohio 43210
Providence St. Vincent Medical Center Portland Oregon 97225
Women and Infants Hospital Providence Rhode Island 02905
Baylor University Medical Center Dallas Texas 75246
Cook Children's Hospital Fort Worth Texas 76104
Texas Health Harris Methodist Hospital Fort Worth Texas 76104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02636868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2021 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02636868 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →